186 related articles for article (PubMed ID: 15324309)
21. Rac1 GTPase silencing counteracts microgravity-induced effects on osteoblastic cells.
Guignandon A; Faure C; Neutelings T; Rattner A; Mineur P; Linossier MT; Laroche N; Lambert C; Deroanne C; Nusgens B; Demets R; Colige A; Vico L
FASEB J; 2014 Sep; 28(9):4077-87. PubMed ID: 24903274
[TBL] [Abstract][Full Text] [Related]
22. Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts.
Id Boufker H; Lagneaux L; Fayyad-Kazan H; Badran B; Najar M; Wiedig M; Ghanem G; Laurent G; Body JJ; Journé F
Bone; 2011 Dec; 49(6):1219-31. PubMed ID: 21893226
[TBL] [Abstract][Full Text] [Related]
23. Butyric acid stimulates bone sialoprotein gene transcription.
Yang L; Li Z; Li X; Wang Z; Wang S; Sasaki Y; Takai H; Ogata Y
J Oral Sci; 2010 Jun; 52(2):231-7. PubMed ID: 20587946
[TBL] [Abstract][Full Text] [Related]
24. Bone sialoprotein (BSP) is a crucial factor for the expression of osteoblastic phenotypes of bone marrow cells cultured on type I collagen matrix.
Mizuno M; Imai T; Fujisawa R; Tani H; Kuboki Y
Calcif Tissue Int; 2000 May; 66(5):388-96. PubMed ID: 10773110
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor-beta 1 regulation of bone sialoprotein gene transcription: identification of a TGF-beta activation element in the rat BSP gene promoter.
Ogata Y; Niisato N; Furuyama S; Cheifetz S; Kim RH; Sugiya H; Sodek J
J Cell Biochem; 1997 Jun; 65(4):501-12. PubMed ID: 9178100
[TBL] [Abstract][Full Text] [Related]
26. Zoledronate attenuates angiogenic effects of angiotensin II-stimulated endothelial progenitor cells via RhoA and MAPK signaling.
Yang JX; Chen B; Pan YY; Han J; Chen F; Hu SJ
PLoS One; 2012; 7(10):e46511. PubMed ID: 23071580
[TBL] [Abstract][Full Text] [Related]
27. Zoledronate has an antitumor effect and induces actin rearrangement in dexamethasone-resistant myeloma cells.
Koizumi M; Nakaseko C; Ohwada C; Takeuchi M; Ozawa S; Shimizu N; Cho R; Nishimura M; Saito Y
Eur J Haematol; 2007 Nov; 79(5):382-91. PubMed ID: 17903213
[TBL] [Abstract][Full Text] [Related]
28. Lysosomal-mitochondrial axis in zoledronic acid-induced apoptosis in human follicular lymphoma cells.
Mitrofan LM; Castells FB; Pelkonen J; Mönkkönen J
J Biol Chem; 2010 Jan; 285(3):1967-79. PubMed ID: 19875454
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor-I increases bone sialoprotein (BSP) expression through fibroblast growth factor-2 response element and homeodomain protein-binding site in the proximal promoter of the BSP gene.
Nakayama Y; Nakajima Y; Kato N; Takai H; Kim DS; Arai M; Mezawa M; Araki S; Sodek J; Ogata Y
J Cell Physiol; 2006 Aug; 208(2):326-35. PubMed ID: 16642470
[TBL] [Abstract][Full Text] [Related]
30. Dickkopf-1 is regulated by the mevalonate pathway in breast cancer.
Rachner TD; Göbel A; Thiele S; Rauner M; Benad-Mehner P; Hadji P; Bauer T; Muders MH; Baretton GB; Jakob F; Ebert R; Bornhäuser M; Schem C; Hofbauer LC
Breast Cancer Res; 2014 Feb; 16(1):R20. PubMed ID: 24528599
[TBL] [Abstract][Full Text] [Related]
31. Modifying the osteoblastic niche with zoledronic acid in vivo-potential implications for breast cancer bone metastasis.
Haider MT; Holen I; Dear TN; Hunter K; Brown HK
Bone; 2014 Sep; 66(100):240-50. PubMed ID: 24971713
[TBL] [Abstract][Full Text] [Related]
32. Bone sialoprotein gene transfer to periodontal ligament cells may not be sufficient to promote mineralization in vitro or in vivo.
Hakki SS; Wang D; Franceschi RT; Somerman MJ
J Periodontol; 2006 Feb; 77(2):167-73. PubMed ID: 16460240
[TBL] [Abstract][Full Text] [Related]
33. Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells.
Ubellacker JM; Haider MT; DeCristo MJ; Allocca G; Brown NJ; Silver DP; Holen I; McAllister SS
Breast Cancer Res; 2017 Mar; 19(1):23. PubMed ID: 28264701
[TBL] [Abstract][Full Text] [Related]
34. Static magnetic fields-induced bone sialoprotein (BSP) expression is mediated through FGF2 response element and pituitary-specific transcription factor-1 motif.
Shimizu E; Matsuda-Honjyo Y; Samoto H; Saito R; Nakajima Y; Nakayama Y; Kato N; Yamazaki M; Ogata Y
J Cell Biochem; 2004 Apr; 91(6):1183-96. PubMed ID: 15048873
[TBL] [Abstract][Full Text] [Related]
35. Endothelin-1 regulates rat bone sialoprotein gene transcription.
Li X; Wang Z; Yang L; Li Z; Ogata Y
J Oral Sci; 2010 Jun; 52(2):221-9. PubMed ID: 20587945
[TBL] [Abstract][Full Text] [Related]
36. Identification of FGF2-response element in the rat bone sialoprotein gene promoter.
Shimizu-Sasaki E; Yamazaki M; Furuyama S; Sugiya H; Sodek J; Ogata Y
Connect Tissue Res; 2003; 44 Suppl 1():103-8. PubMed ID: 12952182
[TBL] [Abstract][Full Text] [Related]
37. GTPases RhoA and Rac1 are important for amelogenin and DSPP expression during differentiation of ameloblasts and odontoblasts.
Biz MT; Marques MR; Crema VO; Moriscot AS; dos Santos MF
Cell Tissue Res; 2010 Jun; 340(3):459-70. PubMed ID: 20387077
[TBL] [Abstract][Full Text] [Related]
38. Zoledronic acid decreases mRNA six-transmembrane epithelial antigen of prostate protein expression in prostate cancer cells.
Valenti MT; Giannini S; Donatelli L; Realdi G; Lo Cascio V; Dalle Carbonare L
J Endocrinol Invest; 2010 Apr; 33(4):244-9. PubMed ID: 19915386
[TBL] [Abstract][Full Text] [Related]
39. Kaempferol stimulates bone sialoprotein gene transcription and new bone formation.
Yang L; Takai H; Utsunomiya T; Li X; Li Z; Wang Z; Wang S; Sasaki Y; Yamamoto H; Ogata Y
J Cell Biochem; 2010 Aug; 110(6):1342-55. PubMed ID: 20564228
[TBL] [Abstract][Full Text] [Related]
40. In vitro mineralization studies with substrate-immobilized bone morphogenetic protein peptides.
Kirkwood K; Rheude B; Kim YJ; White K; Dee KC
J Oral Implantol; 2003; 29(2):57-65. PubMed ID: 12760448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
